211 related articles for article (PubMed ID: 35272484)
1. NF-κB Signaling-Mediated Activation of WNK-SPAK-NKCC1 Cascade in Worsened Stroke Outcomes of Ang II-Hypertensive Mice.
Bhuiyan MIH; Young CB; Jahan I; Hasan MN; Fischer S; Meor Azlan NF; Liu M; Chattopadhyay A; Huang H; Kahle KT; Zhang J; Poloyac SM; Molyneaux BJ; Straub AC; Deng X; Gomez D; Sun D
Stroke; 2022 May; 53(5):1720-1734. PubMed ID: 35272484
[TBL] [Abstract][Full Text] [Related]
2. Role of SPAK-NKCC1 signaling cascade in the choroid plexus blood-CSF barrier damage after stroke.
Wang J; Liu R; Hasan MN; Fischer S; Chen Y; Como M; Fiesler VM; Bhuiyan MIH; Dong S; Li E; Kahle KT; Zhang J; Deng X; Subramanya AR; Begum G; Yin Y; Sun D
J Neuroinflammation; 2022 Apr; 19(1):91. PubMed ID: 35413993
[TBL] [Abstract][Full Text] [Related]
3. Dietary salt intake regulates WNK3-SPAK-NKCC1 phosphorylation cascade in mouse aorta through angiotensin II.
Zeniya M; Sohara E; Kita S; Iwamoto T; Susa K; Mori T; Oi K; Chiga M; Takahashi D; Yang SS; Lin SH; Rai T; Sasaki S; Uchida S
Hypertension; 2013 Nov; 62(5):872-8. PubMed ID: 24019400
[TBL] [Abstract][Full Text] [Related]
4. WNK-Cab39-NKCC1 signaling increases the susceptibility to ischemic brain damage in hypertensive rats.
Bhuiyan MIH; Song S; Yuan H; Begum G; Kofler J; Kahle KT; Yang SS; Lin SH; Alper SL; Subramanya AR; Sun D
J Cereb Blood Flow Metab; 2017 Aug; 37(8):2780-2794. PubMed ID: 27798271
[TBL] [Abstract][Full Text] [Related]
5. SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation.
Thastrup JO; Rafiqi FH; Vitari AC; Pozo-Guisado E; Deak M; Mehellou Y; Alessi DR
Biochem J; 2012 Jan; 441(1):325-37. PubMed ID: 22032326
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of WNK3 Kinase Signaling Reduces Brain Damage and Accelerates Neurological Recovery After Stroke.
Begum G; Yuan H; Kahle KT; Li L; Wang S; Shi Y; Shmukler BE; Yang SS; Lin SH; Alper SL; Sun D
Stroke; 2015 Jul; 46(7):1956-1965. PubMed ID: 26069258
[TBL] [Abstract][Full Text] [Related]
7. A Novel Na
Huang H; Bhuiyan MIH; Jiang T; Song S; Shankar S; Taheri T; Li E; Schreppel P; Hintersteininger M; Yang SS; Lin SH; Molyneaux BJ; Zhang Z; Erker T; Sun D
Stroke; 2019 Apr; 50(4):1021-1025. PubMed ID: 30862257
[TBL] [Abstract][Full Text] [Related]
8. Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1.
Vitari AC; Thastrup J; Rafiqi FH; Deak M; Morrice NA; Karlsson HK; Alessi DR
Biochem J; 2006 Jul; 397(1):223-31. PubMed ID: 16669787
[TBL] [Abstract][Full Text] [Related]
9. A novel Ste20-related proline/alanine-rich kinase (SPAK)-independent pathway involving calcium-binding protein 39 (Cab39) and serine threonine kinase with no lysine member 4 (WNK4) in the activation of Na-K-Cl cotransporters.
Ponce-Coria J; Markadieu N; Austin TM; Flammang L; Rios K; Welling PA; Delpire E
J Biol Chem; 2014 Jun; 289(25):17680-8. PubMed ID: 24811174
[TBL] [Abstract][Full Text] [Related]
10. Effect of heterozygous deletion of WNK1 on the WNK-OSR1/ SPAK-NCC/NKCC1/NKCC2 signal cascade in the kidney and blood vessels.
Susa K; Kita S; Iwamoto T; Yang SS; Lin SH; Ohta A; Sohara E; Rai T; Sasaki S; Alessi DR; Uchida S
Clin Exp Nephrol; 2012 Aug; 16(4):530-8. PubMed ID: 22294159
[TBL] [Abstract][Full Text] [Related]
11. WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.
Thomson MN; Cuevas CA; Bewarder TM; Dittmayer C; Miller LN; Si J; Cornelius RJ; Su XT; Yang CL; McCormick JA; Hadchouel J; Ellison DH; Bachmann S; Mutig K
Am J Physiol Renal Physiol; 2020 Jan; 318(1):F216-F228. PubMed ID: 31736353
[TBL] [Abstract][Full Text] [Related]
12. Suppression of WNK1-SPAK/OSR1 Attenuates Bone Cancer Pain by Regulating NKCC1 and KCC2.
Gao JL; Peng K; Shen MW; Hou YH; Qian XB; Meng XW; Ji FH; Wang LN; Yang JP
J Pain; 2019 Dec; 20(12):1416-1428. PubMed ID: 31085334
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.
Nishida H; Sohara E; Nomura N; Chiga M; Alessi DR; Rai T; Sasaki S; Uchida S
Hypertension; 2012 Oct; 60(4):981-90. PubMed ID: 22949526
[TBL] [Abstract][Full Text] [Related]
14. Modulation of brain cation-Cl
Zhang J; Bhuiyan MIH; Zhang T; Karimy JK; Wu Z; Fiesler VM; Zhang J; Huang H; Hasan MN; Skrzypiec AE; Mucha M; Duran D; Huang W; Pawlak R; Foley LM; Hitchens TK; Minnigh MB; Poloyac SM; Alper SL; Molyneaux BJ; Trevelyan AJ; Kahle KT; Sun D; Deng X
Nat Commun; 2020 Jan; 11(1):78. PubMed ID: 31911626
[TBL] [Abstract][Full Text] [Related]
15. Chemical library screening for WNK signalling inhibitors using fluorescence correlation spectroscopy.
Mori T; Kikuchi E; Watanabe Y; Fujii S; Ishigami-Yuasa M; Kagechika H; Sohara E; Rai T; Sasaki S; Uchida S
Biochem J; 2013 Nov; 455(3):339-45. PubMed ID: 23981180
[TBL] [Abstract][Full Text] [Related]
16. Modulation of NCC activity by low and high K(+) intake: insights into the signaling pathways involved.
Castañeda-Bueno M; Cervantes-Perez LG; Rojas-Vega L; Arroyo-Garza I; Vázquez N; Moreno E; Gamba G
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1507-19. PubMed ID: 24761002
[TBL] [Abstract][Full Text] [Related]
17. SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation.
Chu PY; Cheng CJ; Wu YC; Fang YW; Chau T; Uchida S; Sasaki S; Yang SS; Lin SH
PLoS One; 2013; 8(9):e72969. PubMed ID: 24039833
[TBL] [Abstract][Full Text] [Related]
18. SPAK inhibitor ZT-1a attenuates reactive astrogliosis and oligodendrocyte degeneration in a mouse model of vascular dementia.
Bhuiyan MIH; Habib K; Sultan MT; Chen F; Jahan I; Weng Z; Rahman MS; Islam R; Foley LM; Hitchens TK; Deng X; Canna SW; Sun D; Cao G
CNS Neurosci Ther; 2024 Mar; 30(3):e14654. PubMed ID: 38433018
[TBL] [Abstract][Full Text] [Related]
19. Arginine vasopressin regulates the renal Na
Carbajal-Contreras H; Murillo-de-Ozores AR; Magaña-Avila G; Marquez-Salinas A; Bourqui L; Tellez-Sutterlin M; Bahena-Lopez JP; Cortes-Arroyo E; Behn-Eschenburg SG; Lopez-Saavedra A; Vazquez N; Ellison DH; Loffing J; Gamba G; Castañeda-Bueno M
Am J Physiol Renal Physiol; 2024 Feb; 326(2):F285-F299. PubMed ID: 38096266
[TBL] [Abstract][Full Text] [Related]
20. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
